Anti-CXCL5 antibody [EPR23928-217]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Anti-CXCL5 antibody [EPR23928-217] is a Rabbit Monoclonal antibody that is used in CXCL5 Flow Cytometry (Intra), ICC/IF, IP, Western Blot. Suitable for Human samples.
CXCL5, also known as C-X-C motif chemokine ligand 5 is a chemokine involved in the recruitment and activation of immune cells, and its dysregulation has been linked to various aspects of tumor progression, including metastasis and angiogenesis.CXCL5 contributes to the formation of an immunosuppressive tumor microenvironment. Monocytic MDSCs (macrophages) can be recruited into the tumour microenvironment by CCL2. The CXCL5–CXCR2 and CXCL12–CXCR4 signalling pathways are also reported to be involved in MDSC trafficking in a breast tumour mouse model. CXCL5 has been identified as a potential prognostic marker in certain cancers.
View Alternative Names
ENA78, SCYB5, CXCL5, C-X-C motif chemokine 5, ENA-78(1-78), Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide ENA-78, Small-inducible cytokine B5
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CXCL5 antibody [EPR23928-217] (AB305100)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized A549 (human lung carcinoma epithelial cell) cells labelling CXCL5 with ab305100 at 1/500 (1.012 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing increased cytoplasmic staining in A549 cells treated with starved overnight, then add TPA (10 nM), TNF alpha (10 ng/ml) and BSA (0.1%) for 24 h and treated with BFA (300 ng/ml) for another 3 h. The image was taken with a confocal microscope (Leica-Microsystems, TCS SP8). is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5 ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CXCL5 antibody [EPR23928-217] (AB305100)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized A549 (human lung carcinoma epithelial cell) treated with 10ng/ml TNF alpha and 10nM TPA and 0.1% BSA for 24 hours, then add 300ng/ml BFA for another 3 hours (Red) / Untreated control (Green) cells labelling CXCL5 with ab305100 at 1/500 dilution (0.1ug) (Red) and Green (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-CXCL5 antibody [EPR23928-217] (AB305100)
CXCL5 was immunoprecipitated from 0.35 mg A549 (human lung carcinoma epithelial cell) starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (ab120297), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate 10 µg with ab305100 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab305100 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : A549 (human lung carcinoma epithelial cell) starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (ab120297), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate 10 µg
Lane 2 : ab305100 IP in A549 starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (ab120297), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab305069 in A549 starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (ab120297), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 minutes.
All lanes:
Immunoprecipitation - Anti-CXCL5 antibody [EPR23928-217] (ab305100) at 1/1000 dilution
Lane 1:
A549 (human lung carcinoma epithelial cell) starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (<a href='/en-us/products/biochemicals/phorbol-12-myristate-13-acetate-pma-pkc-activator-ab120297'>ab120297</a>), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole
Lane 2:
ab305100 IP in A549 starved overnight, then treated with 10 ng/ml TNF alpha, 10 nM TPA (<a href='/en-us/products/biochemicals/phorbol-12-myristate-13-acetate-pma-pkc-activator-ab120297'>ab120297</a>), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 12 kDa
Observed band size: 12 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-CXCL5 antibody [EPR23928-217] (AB305100)
Blocking and diluting buffer and concentration : 5% NFDM/TBST This antibody does not cross-react with human CXCL6. Exposure time : 37 seconds
All lanes:
Western blot - Anti-CXCL5 antibody [EPR23928-217] (ab305100) at 1/1000 dilution
Lane 1:
HEK-293T cells transfected with a human CXCL5 expression vector containing a myc-his tag, then treated with 600 /ml BFA (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) for 3h, whole cell lysate at 20 µg
Lane 2:
HEK-293T cells transfected with a human CXCL6 expression vector containing a myc-his tag, then treated with 600 /ml BFA (<a href='/en-us/products/biochemicals/brefeldin-a-inhibitor-of-adp-ribosylation-factor-ab120299'>ab120299</a>) for 3h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 16 kDa
false
Exposure time: 37s
- WB
Supplier Data
Western blot - Anti-CXCL5 antibody [EPR23928-217] (AB305100)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The expression of CXCL5 is upregulated in response to TNF-a and PMA treatment (PMID : 9057843; PMID : 23922745). The identity of the higher MW band at approximately 70 kDa is unknown. Exposure time : 125 seconds
All lanes:
Western blot - Anti-CXCL5 antibody [EPR23928-217] (ab305100) at 1/1000 dilution
Lane 1:
A549 (human lu carcinoma epithelial cell) starved overnight, whole cell lysate at 20 µg
Lane 2:
A549 starved overnight, then treated with /ml TNF alpha, 10 nM TPA (<a href='/en-us/products/biochemicals/phorbol-12-myristate-13-acetate-pma-pkc-activator-ab120297'>ab120297</a>), and 0.1% BSA for 24h, then with 300 ng/ml BFA added for 3h, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 12 kDa
false
Exposure time: 125s
Related conjugates and formulations (1)
-
Anti-CXCL5 antibody [EPR23928-217] - BSA and Azide free
Reactivity data
Product details
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL5 affects inflammation and the immune response by modulating neutrophil recruitment to sites of infection or injury. It is a part of the larger network of chemokines that direct leukocyte movement throughout the body. While CXCL5 does not form a complex in a traditional sense it does interact dynamically with CXCR2 receptor to exert its effects. These interactions are pivotal to the protein’s role in orchestrating the immune system’s response to diverse stimuli.
Pathways
CXCL5 plays a part in the chemokine signaling pathway and the inflammatory response pathway. These pathways are important in mediating immune surveillance and inflammation. CXCL5 through these pathways has a strong connection to other CXC family proteins like CXCL1 and the receptor CXCR2 which allows for a coordinated response during immune challenges and recovery processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 10:e23312 PubMed38163105
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 24:2274122 PubMed37942533
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 42:133 PubMed37231509
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com